Guide to Omega‑3 Total

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Total omega-3 measures all forms of omega-3 fatty acids in your blood, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), and alpha-linolenic acid (ALA). 

Why It Matters

Omega-3s are essential fatty acids that your body needs but can't make on its own. They serve as building blocks for cell membranes and play vital roles in brain function, heart health, and inflammation control. 

Each type of omega-3 has specific roles: EPA primarily fights inflammation and supports mood. DHA is crucial for brain and eye function. And DPA acts as a storage form that can convert to either EPA or DHA when needed. ALA, found in plant foods, is a precursor that your body can convert into these more active forms. 

Total omega-3 measurement shows your combined levels of all these forms. This is important because your body can convert certain omega-3s based on its needs. For example, if you're fighting inflammation, your body might use more EPA; if you're healing nerve tissue, it might need more DHA. Having adequate total omega-3s ensures your body has enough raw material for all these functions.

Omega-3 deficiency can develop slowly and affect many body systems. Since omega-3s compete with omega-6 fatty acids for use in your body, having enough total omega-3s helps maintain a healthy balance between inflammatory and anti-inflammatory processes.

Associated Symptoms

Omega-3 levels themselves are laboratory findings rather than medical conditions. However, suboptimal omega-3 status may be associated with certain health conditions, each with its own symptoms.

Conditions potentially associated with low omega-3 status:

  • Inflammatory disorders: Joint pain and stiffness, chronic inflammation
  • Cardiovascular conditions: May contribute to irregular heartbeat, blood pressure variations
  • Mood disorders: Depression, anxiety, irritability (omega-3s play a role in brain function)
  • Cognitive changes: Poor concentration, memory issues (DHA is a major structural component of the brain)
  • Skin conditions: Dry skin, eczema and psoriasis flare-ups, poor wound healing
  • Eye health issues: Dry eyes (DHA is concentrated in the retina)
  • Pregnancy: The need for omega-3's increases during pregnancy because omega-3's are important for the development of the baby's eyes, brain, and nervous system. The need increases by the baby, which can decrease levels in the mom.

Conditions potentially associated with excessively high omega-3 levels (rare, usually from excessive supplementation):

  • Bleeding disorders: Increased bleeding time, easier bruising may be due to omega-3's mild anticoagulant effects
  • Digestive disturbances: Diarrhea, constipation, nausea, fishy aftertaste (typically from supplements)
  • Medication interactions: Enhanced effects of blood thinners or antiplatelet medications
  • Immune Dysfunction: Can affect the body's ability to fight microbial pathogens

It's important to note that these relationships are complex and often bidirectional. Many factors beyond omega-3 levels influence these health conditions, and symptoms can be caused by numerous other factors. Your doctor will consider omega-3 status as one piece of your overall health picture.

Clinical Ranges

Lab Reference Range: > 5.4 % by wt

Lifestyle Factors That Can Impact It

Activities that increase total omega-3 levels include:

  • Regular consumption of omega-3-rich foods:
  • Fatty fish (highest sources, providing EPA and DHA):
  • Salmon (wild-caught has 2-3 times more omega-3s than farmed)
  • Mackerel (especially Atlantic and Pacific mackerel)
  • Sardines
  • Herring
  • Anchovies
  • Trout
  • Plant sources (providing ALA, which converts to EPA and DHA at low rates):
  • Flaxseeds and flaxseed oil
  • Chia seeds
  • Walnuts
  • Hemp seeds
  • Algal oil (a vegan source that directly provides DHA)
  • Balanced omega-6 to omega-3 ratio: Reducing intake of processed foods high in vegetable oils helps optimize this balance

Activities that decrease total omega-3 levels include:

  • A high omega-6 diet: Ultra-processed foods, vegetable oils (corn, soybean, safflower), and fried foods can compete with omega-3 absorption and utilization
  • Chronic stress: Increases omega-3 depletion through oxidative stress and inflammatory processes
  • Poor sleep: Raises inflammation and increases omega-3 usage
  • Excessive alcohol use: Impairs omega-3 absorption and utilization

Other Factors That Can Impact It

Medical Conditions

  • Inflammatory diseases: decrease levels by using up omega-3s faster
  • Diabetes: lowers levels by altering fat metabolism
  • Liver disease: reduces levels by increasing utilization, and impairing synthesis and fat processing
  • Digestive disorders: decrease absorption of omega-3s
  • Thyroid problems: affect fat metabolism
  • Autoimmune conditions: deplete omega-3s through inflammation

Medications

  • Blood thinners: don't change levels but compound omega-3's anticoagulant effects
  • Statins: may decrease levels by affecting fat metabolism
  • Birth control: may lower levels by increasing inflammation and affecting fat processing
  • NSAIDs: might help preserve omega-3 levels by lowering inflammation

Environmental Factors

  • Water quality: Toxins can interfere with the production of omega-3 in the food chain.
  • Air pollution: Increases omega-3 usage through oxidative stress.

Testing Accuracy and Stability

Total omega-3 testing provides a more stable measurement than individual omega-3 tests. However, several factors can still affect results. Understanding these factors helps ensure accurate assessment.

Factors That Can Affect Your Test Results

  • Recent meals with fatty fish can increase levels for several days.
  • Fish oil supplements can affect levels for up to two weeks.
  • Inflammation from a recent illness temporarily lowers levels.

How It Relates to Other Markers

Other tests can provide insights about health status when they're viewed alongside total omega-3 results. These tests may include:

  • Total omega-6: Higher levels compete with omega-3s and lead to lower total omega-3.
  • Omega-3 index: This index measures the percent of DHA and EPA in the membranes of red blood cells, and helps validate results.
  • Individual omega-3s: Low EPA, DHA, or DPA may suggest reasons for low total omega-3.
  • Inflammatory markers: High inflammation can deplete  omega-3s, lowering total levels.
  • Triglycerides: High levels can indicate problems that may be lowering omega-3 absorption.
  • Vitamin D: Low levels can reduce fatty acid metabolism.
  • Insulin: High levels can increase inflammation and omega-3 utilization.
  • Liver function tests: Poor liver function can reduce omega-3 synthesis and fat.

Follow-up Considerations

If your total omega-3 levels are low, your provider may work with you on a plan to address any levels that are out of range. Their recommendations may include the following. You should always speak to your doctor if you have medical questions or before making medical decisions. 

When Re-Testing May be Appropriate

  • Normal levels: Every 6--12 months
  • Low levels: Every 3 months until normalized
  • During supplementation: Every 3--4 months
  • Inflammatory conditions: Every 3 months
  • Pregnancy: With routine labs

Additional Testing Your Doctor May Consider

  • Omega-6/omega-3 ratio
  • Inflammatory markers
  • Cardiovascular risk markers
  • Oxidative stress markers

When Additional Care May be Warranted

  • Persistently low levels despite supplementation
  • High inflammation with low omega-3s
  • Cardiovascular symptoms
  • Poor conversion patterns
  • Multiple fatty acid imbalances

Further Reading

Why omega 3s are crucial to strong metabolic health

Bibliography

References

1. Harris, William S., et al. "The Omega-3 Index: Clinical Utility for Therapeutic Intervention." Current Cardiology Reports, vol. 12, no. 6, 2010, pp. 503--508. https://doi.org/10.1007/s11886-017-0910-1.

2. Calder, Philip C. "Very Long-Chain n-3 Fatty Acids and Human Health: Fact, Fiction and the Future." Proceedings of the Nutrition Society, vol. 77, no. 1, 2018, pp. 52--72. https://doi.org/10.1017/S0029665117003950.

3. Stark, Ken D., et al. "Global Survey of the Omega-3 Fatty Acids, Docosahexaenoic Acid and Eicosapentaenoic Acid in the Bloodstream of Healthy Adults." Progress in Lipid Research, vol. 63, 2016, pp. 132--152. https://doi.org/10.1016/j.plipres.2016.05.001.

4. Christensen, Jeppe H. "Omega-3 Fatty Acids and Heart Rate Variability." Frontiers in Physiology, vol. 2, 2011, article 84. https://doi.org/10.3389/fphys.2011.00084.

5. Martinsen, Bjørn K., et al. "Quantitative Determination of EPA, DPA, and DHA in Human Plasma by High-Throughput NMR Metabolomics." Journal of Proteome Research, vol. 18, no. 3, 2019, pp. 1178--1185. https://doi.org/10.1021/acs.jproteome.8b00762.

6. Block, Robert C., et al. "Effects of Omega-3 and Aspirin on Inflammatory Cytokines and Angiogenesis Factors." World Journal of Cardiovascular Diseases, vol. 2, no. 1, 2012, pp. 14--19. https://doi.org/10.4236/wjcd.2012.21003.

7. Mozaffarian, Dariush, et al. "Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults." Annals of Internal Medicine, vol. 158, no. 7, 2013, pp. 515--525. https://doi.org/10.7326/0003-4819-158-7-201304020-00003.

8. Harris, William S. "The Omega-3 Index: Clinical Utility for Therapeutic Intervention." Current Cardiology Reports, vol. 12, no. 6, 2010, pp. 503--508.

9. Dicklin, Melissa R., et al. "ω-3 Polyunsaturated Fatty Acid Status Testing in Humans: A Narrative Review of Commercially Available Options." Journal of Nutrition, vol. 154, no. 5, 2024, pp. 1487--1504.

10. Kaur, Gaurav, et al. "Short-Term Docosapentaenoic Acid (22:5 n-3) Supplementation Increases Tissue Docosapentaenoic Acid, DHA and EPA Concentrations in Rats." British Journal of Nutrition, vol. 103, no. 1, 2010, pp. 32--37.

11. Byelashov, Oleksandr A., Andrew J. Sinclair, and Gaurav Kaur. "Dietary Sources, Current Intakes, and Nutritional Role of Omega-3 Docosapentaenoic Acid." Lipid Technology, vol. 27, no. 4, 2015, pp. 79--82.

12. Harris, William S., et al. "The Omega-3 Index and Relative Risk for Coronary Heart Disease Mortality: Estimation from 10 Cohort Studies." Atherosclerosis, vol. 262, 2017, pp. 51--54.

13. Calder, Philip C. "Omega-3 Fatty Acids and Inflammatory Processes: From Molecules to Man." Biochemical Society Transactions, vol. 45, no. 5, 2017, pp. 1105--1115.

14. Lands, Bill. "Dietary Omega-3 and Omega-6 Fatty Acids Compete in Producing Tissue Compositions and Tissue Responses." Military Medicine, vol. 179, suppl. 11, 2014, pp. 76--81.

15. DiNicolantonio, James J., and Joseph O'Keefe. "The Importance of Maintaining a Low Omega-6/Omega-3 Ratio for Reducing the Risk of Autoimmune Diseases, Asthma, and Allergies." Missouri Medicine, vol. 118, no. 5, 2021, pp. 453--459.

16. Wierenga, Kelsey A., and James J. Pestka. "Omega-3 Fatty Acids and Inflammation---You Are What You Eat!" Frontiers for Young Minds, vol. 9, 2021, article 601068.

17. Querques, Giuseppe, Romain Forte, and Eric H. Souied. "Retina and Omega-3." Journal of Nutrition and Metabolism, vol. 2011, article 748361.

18. Necyk, Cheryl, et al. "Increased Bruising with the Combination of Long-Chain Omega-3 Fatty Acids, Flaxseed Oil and Clopidogrel." Canadian Pharmacists Journal (Ottawa), vol. 146, no. 2, 2013, pp. 93--96.

19. Simopoulos, Artemis P. "Omega-3 Fatty Acids in Health and Disease and in Growth and Development." American Journal of Clinical Nutrition, vol. 54, no. 3, 1991, pp. 438--463.

20. Krupa, Kevin N., et al. "Omega-3 Fatty Acids." StatPearls, updated 28 Feb. 2024, StatPearls Publishing, 2025.

21. Jensen, Ida J., et al. "An Update on the Content of Fatty Acids, Dioxins, PCBs and Heavy Metals in Farmed, Escaped and Wild Atlantic Salmon (Salmo salar L.) in Norway." Foods, vol. 9, no. 12, 2020, article 1901.

22. Mocking, Roel J.T., et al. "Focus on Fatty Acids in the Neurometabolic Pathophysiology of Psychiatric Disorders." Journal of Inherited Metabolic Disease, vol. 41, no. 4, 2018, pp. 597--611.

23. Shimizu, Koichi, et al. "Effect of Omega-3 Fatty Acids on Sleep: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Journal of Clinical Biochemistry and Nutrition, vol. 75, no. 3, 2024, pp. 204--212.

24. Jackson, Patricia. "Omega-3 Fatty Acids and Sleep: Recent Advances in Understanding Effects and Mechanisms." Current Opinion in Clinical Nutrition and Metabolic Care, vol. 28, no. 2, 2025, pp. 61--65.

25. Cardona, Diana, et al. "Impact of Omega-3 Polyunsaturated Fatty Acids on Alcohol Use and Negative Consequences: A Systematic Review." Nutrition Reviews, 2025, article nuaf036.

26. Zivkovic, Angela M., et al. "Dietary Omega-3 Fatty Acids Aid in the Modulation of Inflammation and Metabolic Health." California Agriculture (Berkeley), vol. 65, no. 3, 2011, pp. 106--111.

27. Sinha, Shivangi, et al. "The Effect of Omega-3 Fatty Acids on Insulin Resistance." Life (Basel), vol. 13, no. 6, 2023, article 1322.

28. Enguita, Maria, et al. "The Cirrhotic Liver is Depleted of Docosahexaenoic Acid (DHA), a Key Modulator of NF-κB and TGFβ Pathways in Hepatic Stellate Cells." Cell Death & Disease, vol. 10, 2019, article 14.

29. Tobin, David, et al. "Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN)." Nutrients, vol. 10, no. 8, 2018, article 1126.

30. Benvenga, Salvatore, et al. "Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsaturated Fatty Acids." Frontiers in Endocrinology (Lausanne), vol. 13, 2022, article 891233. https://doi.org/10.3389/fendo.2022.891233

31. Hong, K., et al. "Association Between Omega-3 Fatty Acids and Autoimmune Disease: Evidence from the Umbrella Review and Mendelian Randomization Analysis." Autoimmunity Reviews, vol. 23, no. 11, 2024, article 103651. https://doi.org/10.1016/j.autrev.2024.103651

32. Ye, Jie, and Subhajit Ghosh. "Omega-3 PUFA vs. NSAIDs for Preventing Cardiac Inflammation." Frontiers in Cardiovascular Medicine, vol. 5, 2018, article 146. https://doi.org/10.3389/fcvm.2018.00146

33. Velichka, Jane, et al. "Elements and Omega-3 Fatty Acids in Fishes Along a Large, Dammed River." Environmental Pollution, vol. 336, 2023, article 122375. https://doi.org/10.1016/j.envpol.2023.122375

34. Chen, Huichao, et al. "Omega-3 Fatty Acids Attenuate Cardiovascular Effects of Short-Term Exposure to Ambient Air Pollution." Particle and Fibre Toxicology, vol. 19, no. 1, 2022, article 12. https://doi.org/10.1186/s12989-022-00441-y

35. Alwayn, Ian, et al. "Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease." Pediatric Research, vol. 57, 2005, pp. 445--452. https://doi.org/10.1203/01.PDR.0000153702.11938.F3

36. Schwarzkopf, Kai M., et al. "Omega-3 and -6 Fatty Acid Plasma Levels Are Not Associated with Liver Cirrhosis-Associated Systemic Inflammation." PLoS ONE, vol. 14, no. 1, 2019, article e0211537. https://doi.org/10.1371/journal.pone.0211537

Sign up for the Levels Newsletter